BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11956113)

  • 1. Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways.
    Eto M; Kozai T; Cosentino F; Joch H; Lüscher TF
    Circulation; 2002 Apr; 105(15):1756-9. PubMed ID: 11956113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and stimulation of phosphatidylinositol 3-kinase but not Akt/endothelial nitric oxide synthase.
    Viswambharan H; Ming XF; Zhu S; Hubsch A; Lerch P; Vergères G; Rusconi S; Yang Z
    Circ Res; 2004 Apr; 94(7):918-25. PubMed ID: 14988229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway.
    Kozai T; Eto M; Yang Z; Shimokawa H; Lüscher TF
    Cardiovasc Res; 2005 Dec; 68(3):475-82. PubMed ID: 16098957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins blunt thrombin-induced down-regulation of endothelial nitric oxide synthase expression in human endothelial cells.
    Eto M; Rathgeb L; Cosentino F; Kozai T; Lüscher TF
    J Cardiovasc Pharmacol; 2006 May; 47(5):663-7. PubMed ID: 16775505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase.
    Eto M; Barandiér C; Rathgeb L; Kozai T; Joch H; Yang Z; Lüscher TF
    Circ Res; 2001 Sep; 89(7):583-90. PubMed ID: 11577023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
    Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH oxidase mediates tissue factor-dependent surface procoagulant activity by thrombin in human vascular smooth muscle cells.
    Herkert O; Diebold I; Brandes RP; Hess J; Busse R; Görlach A
    Circulation; 2002 Apr; 105(17):2030-6. PubMed ID: 11980681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases.
    van Nieuw Amerongen GP; van Delft S; Vermeer MA; Collard JG; van Hinsbergh VW
    Circ Res; 2000 Aug; 87(4):335-40. PubMed ID: 10948069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells.
    Yokoyama K; Ishibashi T; Ohkawara H; Kimura J; Matsuoka I; Sakamoto T; Nagata K; Sugimoto K; Sakurada S; Maruyama Y
    Circulation; 2002 Feb; 105(8):962-7. PubMed ID: 11864926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells.
    Skaletz-Rorowski A; Lutchman M; Kureishi Y; Lefer DJ; Faust JR; Walsh K
    Cardiovasc Res; 2003 Jan; 57(1):253-64. PubMed ID: 12504836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.
    Zhu Y; Casey PJ; Kumar AP; Pervaiz S
    Cell Death Dis; 2013 Apr; 4(4):e568. PubMed ID: 23559002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways.
    Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M
    Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
    Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
    Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.
    Serra N; Rosales R; Masana L; Vallvé JC
    PLoS One; 2015; 10(7):e0133875. PubMed ID: 26207907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of simvastatin on various signal transduction intermediates in cultured human smooth muscle cells.
    Nègre-Aminou P; van Erck M; van Leeuwen RE; Collard JG; Cohen LH
    Biochem Pharmacol; 2001 Apr; 61(8):991-8. PubMed ID: 11286990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High glucose-induced upregulation of osteopontin is mediated via Rho/Rho kinase pathway in cultured rat aortic smooth muscle cells.
    Kawamura H; Yokote K; Asaumi S; Kobayashi K; Fujimoto M; Maezawa Y; Saito Y; Mori S
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):276-81. PubMed ID: 14670931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways.
    Nagaoka T; Hein TW; Yoshida A; Kuo L
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):825-32. PubMed ID: 17251484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery.
    Shiga N; Hirano K; Hirano M; Nishimura J; Nawata H; Kanaide H
    Circ Res; 2005 May; 96(9):1014-21. PubMed ID: 15817883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels.
    Turner NA; O'Regan DJ; Ball SG; Porter KE
    FASEB J; 2005 May; 19(7):804-6. PubMed ID: 15728660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.